Skip to main content
. 2022 Jan 3;37(1):103–116. doi: 10.1007/s10654-021-00824-7

Table 3.

Physical and medical examinations conducted and collected biosamples at baseline (CARLA-0), first (CARLA-1), second (CARLA-2) and third (CARLA-3) follow-up examination

Instrument Time-points
CARLA-0 (N = 1779) CARLA-1 (N = 1436) CARLA-2 (N = 1140) CARLA-3 (N = ongoing)
Anthropometry
Body weight and body height (standing) [15, 72] x x x x
Waist and hip circumference x x x x
Body impedance analysis (BIA) [72] x
3D Body Scanner [72] x
Cardiovascular system
Blood pressure [15, 28] x x x x
Echocardiography, systolic and diastolic function x x x
12-leads Electrocardiogram (20-min and 10-s) [30, 31] x x xa
Ankle–brachial index (ABI) [36)] x x x
Pulse wave analysis (PWA) xb xb
AGE reader (skin autofluorescence) x (N = 368) x
Cognitive function
Mini Mental State Examination xc (N = 1020) x
Semantic memory, episodic memory, working memory [35, 36] x
Numerical reasoning (fluid intelligence), passive vocabulary (crystallized intelligence) [35] x
Attention/executive, motor coordination [35] x
Gait and balance assessment
Timed up and Go Test (TMUG) [39] x
Gait analysis using portable analysis system (Rehagait system) [40] x
Balance assessment using pressure distribution measurement system (Zebris FM System) [41] x
Sensory organ
Olfactory test (Sniffin’ sticks 12) [38] x
Bio-specimens
Serum x x x
EDTA whole blood x x
EDTA plasma x x x
EDTA cellular components x x x
MPA-stabilized EDTA plasma x x
Heparin plasma x x
Citrate plasma x x x
Peripheral blood mononuclear cells x
Urine x x
Stabilized stool x
Physical activity, physical fitness
Hand grip strength [42] x
7-Day accelerometry [43] x

a20-min ECG was not performed. Instead, a 5-min ECG was performed

bSphygmoCor device (CARLA-1) Vascular Explorer (CARLA-3)

cOnly in participants >  = 60yrs